Evidence map›Paper›PMID 40495516›Full record

ArticleJournal of the Turkish German Gynecological Association2025

Determining the optimal follow-up protocol after primary surgery in patients with early-stage endometrial cancer.

Can Ozan Ulusoy, Bulut Varlı, Ali Gökçe, Duygu Altın, Şahin Kaan Baydemir, Uğur Fırat Ortaç, Salih Taşkın

Abstract read
In one paragraph

Article in Journal of the Turkish German Gynecological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Can Ozan UlusoyClinic of Perinatology, University of Health Sciences Türkiye, Etlik City Hospital, Ankara, Türkiye.ORCID 0009-0005-7931-5172
Bulut VarlıDepartment of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Türkiye.ORCID 0000-0002-9072-9393
Ali GökçeDepartment of Gynecologic Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.ORCID 0000-0003-1902-4478
Duygu AltınDepartment of Gynecologic Oncology, Klinikum Bad Salzungen, Thuringia, Germany.ORCID 0000-0002-9072-9393
Şahin Kaan BaydemirClinic of Gynecologic Oncology, University of Health Sciences Türkiye, Etlik City Hospital, Ankara, Türkiye.ORCID 0000-0002-0511-925X
Uğur Fırat OrtaçDepartment of Gynecologic Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.ORCID 0000-0001-6735-5760
Salih TaşkınDepartment of Gynecologic Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.ORCID 0000-0002-9651-2224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study was to investigate the timing of recurrence in patients with early-stage endometrial cancer and to determine the optimal postoperative follow-up protocol for the detection of recurrence. Material and Methods: Patients with stage 1 and 2, grade 1-3 endometrioid type endometrial cancer who underwent follow-up for at least two years were included. The diagnostic method for recurrence was analyzed for each patient. Analysis of risk factors for recurrence were done using SPSS. Sensitivity analyzes were performed comparing the diagnostic methods. Results: A total of 303 patients were included and recurrence was diagnosed in 17 (5.61%). Cumulative risk of recurrence was 3.06% in the first 23 months, rising to 7.52% in the first 33 months. Sensitivity of physical examination (PE) was 50.00%, specificity 99.52%, positive predictive value 88.89%, negative predictive value 96.30% and accuracy rate 96.00% respectively. It was found that each step increase of grade increased recurrence odds by 2.549 times [95% confidence interval (CI): 1.078-6.027; p=0.033] while each step increase of stage increased recurrence odds by 2.943 times (95% CI: 1.270-6.820; p=0.012). Conclusion: It is notable that recurrence rate increased after 25 months and the risk of recurrence increased as the tumor stage and grade worsened. Symptoms in patients with high-grade and deep myometrial invasion, especially after the first two years, should be considered risky and patients should be informed about seeking medical care when symptoms occur. PE and symptoms of patients are key factors in detecting reccurence while other diagnostic methods can be used according to clinical findings.

Indexed as

Endometrium cancerfollow-up protocolreccurence

Identifiers

PMID40495516
PMCPMC12152776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.